The men who received dose escalated radio therapy had less need for secondary therapies, but they did not have any survival advantage.
Stand Up To Cancer announced an initiative that will both help scientists understand the emerging coronavirus pandemic and ensure the needs of cancer patients and survivors are being included as the research goes forward.
